Home Featured 2

Featured 2

Featured posts

Most popular

Global Survey for Pathologists on PD-L1 Testing: Moving Toward Standardization

lungcanc

TTFields in Mesothelioma (The STELLAR Trial): More Stars Needed in the Constellation

Tumor Mutation Burden: Evolution of a Controversial Biomarker From the Pathologist’s Perspective

Smoking Cessation After Cancer Diagnosis: A Neglected Problem

The IASLC Pathology Committee Recommendations for the Use of Diagnostic Immunohistochemistry in Lung Cancer

Artificial Intelligence in Lung Cancer: Opening New Avenues for Detection, Diagnosis,...

lungcanc

Ki-67 in Pulmonary Neuroendocrine Tumors: Where Do We Stand?

lungcanc

Smoking Cessation Prior to Lung Cancer Surgery

lungcanc

Lung Cancer in the Brazilian Health System: Screening, Drug Approvals, Barriers...

lungcanc

Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC

lungcanc

IASLC Journals Share Exciting Milestones on Metrics Journeys

lungcanc

Financial Incentives and Free Treatment Aids for Smoking Cessation in the...

lungcanc

Histologic Transformation From NSCLC to SCLC: A Mechanism of Resistance to...

lungcanc

Consolidating Gains with Chemotherapy in SCLC Maintenance Trials: A Discussion with...

lungcanc

Adjuvant EGFR-TKI for Resected NSCLC: Who, When, and Where?

lungcanc

12 3...7 Page 1 of 7

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib